HLA B5(B51/B52)

Individuals experiencing symptoms suggestive of Behçet’s disease such as recurrent oral or genital ulcers and eye inflammation. Patients with unexplained chronic inflammatory or autoimmune conditions where HLA association is suspected. Those advised by a doctor for genetic susceptibility testing to support diagnosis and clinical management.